StockGlow

Can-Fite BioPharma Ltd. (CANF.TA)

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel.

519.00+0.05%Healthcare
Compare CANF.TA with
StockGlow Score
23
Leaning Bearish
BearishBullish
1 year ago-82.7%

The outlook

Can-Fite BioPharma Ltd. currently reads as leaning bearish based on mixed vs its moving averages, 6% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendMixed vs its moving averages
52-week range6% of the way from its 52-week low to high
Market cap
$22.2M
52-wk high
3,000.00
52-wk low
374.00
50-day avg
481.45
200-day avg
1,201.71
Trailing P/E
—

Similar stocks

BLRX.TABioLineRx Ltd.$1.60+6.67%KMDA.TAKamada Ltd.$2,227.00+3.05%FRSX.TAForesight Autonomous Holdings Ltd.$4.40-2.22%CGEN.TACompugen Ltd.$691.10-1.43%EVGN.TAEvogene Ltd.$162.00+5.13%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy